$5.59M Market Cap.
HCTI Market Cap. (MRY)
HCTI Shares Outstanding (MRY)
HCTI Assets (MRY)
Total Assets
$1.96M
Total Liabilities
$7.08M
Total Investments
$0
HCTI Income (MRY)
Revenue
$11.70M
Net Income
-$5.97M
Operating Expense
$7.64M
HCTI Cash Flow (MRY)
CF Operations
-$1.08M
CF Investing
$0
CF Financing
-$133.00K
HCTI Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | - | - | 0% | - |
HCTI Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $1,961,000 (-80.49%) | $10,049,000 (-51.60%) | $20,763,000 (-15.64%) | $24,613,000 (121.59%) |
Assets Current | $1,452,000 (-74.66%) | $5,729,000 (-26.07%) | $7,749,000 (-34.35%) | $11,804,000 (47.04%) |
Assets Non-Current | $509,000 (-88.22%) | $4,320,000 (-66.80%) | $13,014,000 (1.60%) | $12,809,000 (315.89%) |
Goodwill & Intangible Assets | $0 (0%) | $3,972,000 (-66.51%) | $11,859,000 (0.95%) | $11,747,000 (348.52%) |
Shareholders Equity | -$5,114,000 (-1050.56%) | $538,000 (-95.66%) | $12,388,000 (-23.22%) | $16,135,000 (272.77%) |
Property Plant & Equipment Net | $12,000 (-72.73%) | $44,000 (-45.00%) | $80,000 (-67.48%) | $246,000 (1458.34%) |
Cash & Equivalents | $20,000 (-98.38%) | $1,234,000 (-7.98%) | $1,341,000 (-24.24%) | $1,770,000 (26.19%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $1,607,000 (-54.60%) | $3,540,000 (-46.90%) | $6,667,000 (-36.43%) | $10,488,000 (53.31%) |
Trade & Non-Trade Payables | $2,539,000 (30.01%) | $1,953,000 (31.87%) | $1,481,000 (-20.93%) | $1,873,000 (-56.94%) |
Accumulated Retained Earnings (Deficit) | -$33,571,000 (-34.80%) | -$24,905,000 (-98.16%) | -$12,568,000 (-371.77%) | -$2,664,000 (-181.07%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $2,650,000 (-38.61%) | $4,317,000 (78.98%) | $2,412,000 (-30.17%) | $3,454,000 (357.85%) |
Debt Current | $2,650,000 (-22.72%) | $3,429,000 (42.16%) | $2,412,000 (-30.17%) | $3,454,000 (357.85%) |
Debt Non-Current | $0 (0%) | $888,000 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $7,075,000 (-25.61%) | $9,511,000 (13.56%) | $8,375,000 (-1.21%) | $8,478,000 (25.06%) |
Liabilities Current | $7,075,000 (-12.90%) | $8,123,000 (32.12%) | $6,148,000 (-1.65%) | $6,251,000 (-7.79%) |
Liabilities Non-Current | $0 (0%) | $1,388,000 (-37.67%) | $2,227,000 (0.00%) | $2,227,000 (0%) |
HCTI Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $11,696,000 (-64.77%) | $33,203,000 (-27.64%) | $45,886,000 (30.10%) | $35,270,000 (12.54%) |
Cost of Revenue | $8,806,000 (-66.68%) | $26,426,000 (-23.60%) | $34,591,000 (39.77%) | $24,748,000 (8.77%) |
Selling General & Administrative Expense | $6,153,000 (-39.04%) | $10,094,000 (-18.49%) | $12,383,000 (34.58%) | $9,201,000 (89.21%) |
Research & Development Expense | $429,000 (-46.31%) | $799,000 (-86.58%) | $5,953,000 (13.24%) | $5,257,000 (201.59%) |
Operating Expenses | $7,641,000 (-57.84%) | $18,125,000 (-16.51%) | $21,710,000 (36.71%) | $15,880,000 (114.33%) |
Interest Expense | $1,213,000 (25.31%) | $968,000 (356.60%) | $212,000 (-62.61%) | $567,000 (620.95%) |
Income Tax Expense | $12,000 (-65.71%) | $35,000 (-44.44%) | $63,000 (162.50%) | $24,000 (-90.68%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$5,969,000 (51.62%) | -$12,339,000 (-28.40%) | -$9,610,000 (-61.54%) | -$5,949,000 (-352.78%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$5,969,000 (51.62%) | -$12,339,000 (-28.40%) | -$9,610,000 (-61.54%) | -$5,949,000 (-352.78%) |
Preferred Dividends Income Statement Impact | $7,435,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$5,969,000 (51.62%) | -$12,339,000 (-28.40%) | -$9,610,000 (-61.54%) | -$5,949,000 (-352.78%) |
Weighted Average Shares | $5,278,293 (24.82%) | $4,228,741 (15.10%) | $3,674,065 (24.85%) | $2,942,786 (5.48%) |
Weighted Average Shares Diluted | $5,278,293 (24.82%) | $4,228,741 (15.10%) | $3,674,065 (24.85%) | $2,942,786 (5.48%) |
Earning Before Interest & Taxes (EBIT) | -$4,744,000 (58.15%) | -$11,336,000 (-21.44%) | -$9,335,000 (-74.23%) | -$5,358,000 (-299.22%) |
Gross Profit | $2,890,000 (-57.36%) | $6,777,000 (-40.00%) | $11,295,000 (7.35%) | $10,522,000 (22.55%) |
Operating Income | -$4,751,000 (58.13%) | -$11,348,000 (-8.96%) | -$10,415,000 (-94.38%) | -$5,358,000 (-555.34%) |
HCTI Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | -$13,000 (99.61%) | -$3,319,000 (56.49%) | -$7,629,000 (-1497.84%) |
Net Cash Flow from Financing | -$133,000 (-108.76%) | $1,518,000 (-72.35%) | $5,490,000 (-63.66%) | $15,108,000 (821.22%) |
Net Cash Flow from Operations | -$1,081,000 (32.94%) | -$1,612,000 (38.00%) | -$2,600,000 (63.44%) | -$7,112,000 (-868.05%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$1,214,000 (-1034.58%) | -$107,000 (75.06%) | -$429,000 (-216.89%) | $367,000 (-14.23%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | -$13,000 (67.50%) | -$40,000 (49.37%) | -$79,000 (0%) |
Issuance (Repayment) of Debt Securities | -$1,089,000 (-206.97%) | $1,018,000 (11211.11%) | $9,000 (-98.99%) | $888,000 (-45.85%) |
Issuance (Purchase) of Equity Shares | $956,000 (91.20%) | $500,000 (-91.34%) | $5,775,000 (-59.39%) | $14,220,000 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $109,000 (60.29%) | $68,000 (-82.15%) | $381,000 (-68.14%) | $1,196,000 (0%) |
Depreciation Amortization & Accretion | $889,000 (-87.71%) | $7,232,000 (114.34%) | $3,374,000 (137.27%) | $1,422,000 (77.04%) |
HCTI Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 24.70% (21.08%) | 20.40% (-17.07%) | 24.60% (-17.45%) | 29.80% (8.76%) |
Profit Margin | -51.00% (-37.10%) | -37.20% (-77.99%) | -20.90% (-23.67%) | -16.90% (-325.33%) |
EBITDA Margin | -33.00% (-166.13%) | -12.40% (4.62%) | -13.00% (-16.07%) | -11.20% (-200.90%) |
Return on Average Equity (ROAE) | 295.20% (243.65%) | -205.50% (-213.26%) | -65.60% (-12.91%) | -58.10% (-177.78%) |
Return on Average Assets (ROAA) | -121.70% (-46.63%) | -83.00% (-94.84%) | -42.60% (-27.93%) | -33.30% (-237.04%) |
Return on Sales (ROS) | -40.60% (-19.06%) | -34.10% (-67.98%) | -20.30% (-33.55%) | -15.20% (-276.74%) |
Return on Invested Capital (ROIC) | 242.00% (149.20%) | -491.90% (-192.80%) | -168.00% (-46.72%) | -114.50% (83.42%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.87 (7.13%) | -0.94 (-37.03%) | -0.69 (92.34%) | -8.96 |
Price to Sales Ratio (P/S) | 0.45 (27.14%) | 0.35 (143.06%) | 0.14 (-90.46%) | 1.51 |
Price to Book Ratio (P/B) | -1.09 (-105.01%) | 21.82 (3513.41%) | 0.6 (-86.17%) | 4.37 |
Debt to Equity Ratio (D/E) | -1.38 (-107.82%) | 17.68 (2515.09%) | 0.68 (28.76%) | 0.53 (-66.48%) |
Earnings Per Share (EPS) | -1.13 (61.30%) | -2.92 (-11.45%) | -2.62 (-29.70%) | -2.02 (-340.48%) |
Sales Per Share (SPS) | 2.22 (-71.78%) | 7.85 (-37.13%) | 12.49 (4.21%) | 11.98 (6.69%) |
Free Cash Flow Per Share (FCFPS) | -0.2 (46.61%) | -0.38 (46.59%) | -0.72 (70.58%) | -2.44 (-829.28%) |
Book Value Per Share (BVPS) | -0.97 (-862.99%) | 0.13 (-96.23%) | 3.37 (-38.50%) | 5.48 (253.51%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.37 (-74.11%) | 1.44 (-40.69%) | 2.42 (-44.58%) | 4.37 (43.72%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (0.00%) | -1 (0.00%) | -1 (92.86%) | -14 |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.72 (53.32%) | -3.69 (-277.40%) | -0.98 (94.68%) | -18.38 |
Asset Turnover | 2.38 (6.76%) | 2.23 (9.89%) | 2.03 (2.94%) | 1.98 (-39.01%) |
Current Ratio | 0.2 (-70.92%) | 0.7 (-44.05%) | 1.26 (-33.26%) | 1.89 (59.46%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$1,081,000 (33.48%) | -$1,625,000 (38.45%) | -$2,640,000 (63.29%) | -$7,191,000 (-878.80%) |
Enterprise Value (EV) | $6,643,713 (-56.14%) | $15,145,935 (159.72%) | $5,831,671 (-91.94%) | $72,351,910 |
Earnings Before Tax (EBT) | -$5,957,000 (51.58%) | -$12,304,000 (-28.88%) | -$9,547,000 (-61.13%) | -$5,925,000 (-326.94%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$3,855,000 (6.07%) | -$4,104,000 (31.15%) | -$5,961,000 (-51.45%) | -$3,936,000 (-212.69%) |
Invested Capital | -$2,484,000 (-339.54%) | $1,037,000 (-72.90%) | $3,827,000 (-53.89%) | $8,299,000 (682.19%) |
Working Capital | -$5,623,000 (-134.88%) | -$2,394,000 (-249.53%) | $1,601,000 (-71.17%) | $5,553,000 (344.77%) |
Tangible Asset Value | $1,961,000 (-67.73%) | $6,077,000 (-31.75%) | $8,904,000 (-30.79%) | $12,866,000 (51.57%) |
Market Capitalization | $5,589,713 (-52.40%) | $11,741,935 (56.94%) | $7,481,671 (-89.38%) | $70,479,137 |
Average Equity | -$2,022,250 (-133.68%) | $6,004,750 (-58.99%) | $14,642,500 (43.11%) | $10,231,685 (224.65%) |
Average Assets | $4,905,000 (-66.99%) | $14,860,750 (-34.16%) | $22,570,750 (26.37%) | $17,860,282 (84.51%) |
Invested Capital Average | -$1,960,250 (-185.05%) | $2,304,750 (-58.52%) | $5,556,500 (18.73%) | $4,679,997 (1301.51%) |
Shares | 5,666,781 (32.48%) | 4,277,572 (2.74%) | 4,163,423 (6.92%) | 3,893,875 (0.00%) |
